Anthera Pharmaceuticals OverviewAnthera Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for ANTH.
Quarterly Other Income/Expense
$3.25M
↑ 638.47% YoY
As of Mar 31, 2018
Annual Other Income/Expense (TTM)
$13.41M
↑ 1164.91% YoY
Trailing 12 months ending Mar 31, 2018